Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.

Gutsche A, Grabowska W, Altrichter S, Grekowitz E, Roll S, Heine G, Staubach P, Pfützner W, Brehler R, Bauer A, Wagner N, Wurpts G, Salameh P, Salehzadeh-Yazdi A, Jahandideh SS, Metz M

Open source

DOI
10.1111/all.70454
Published
2026 Jul 31
Container
Allergy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/all.70454,
  title = {Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.},
  author = {Gutsche A and Grabowska W and Altrichter S and Grekowitz E and Roll S and Heine G and Staubach P and Pfützner W and Brehler R and Bauer A and Wagner N and Wurpts G and Salameh P and Salehzadeh-Yazdi A and Jahandideh SS and Metz M},
  year = {2026},
  journal = {Allergy},
  doi = {10.1111/all.70454},
  url = {https://doi.org/10.1111/all.70454}
}

RIS

TY  - JOUR
TI  - Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.
AU  - Gutsche A
AU  - Grabowska W
AU  - Altrichter S
AU  - Grekowitz E
AU  - Roll S
AU  - Heine G
AU  - Staubach P
AU  - Pfützner W
AU  - Brehler R
AU  - Bauer A
AU  - Wagner N
AU  - Wurpts G
AU  - Salameh P
AU  - Salehzadeh-Yazdi A
AU  - Jahandideh SS
AU  - Metz M
PY  - 2026
JO  - Allergy
DO  - 10.1111/all.70454
UR  - https://doi.org/10.1111/all.70454
ER  - 

APA

A, G., W, G., S, A., E, G., S, R., G, H., P, S., W, P., R, B., A, B., N, W., G, W., P, S., A, S., SS, J., & M, M. (2026). Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.. Allergy. https://doi.org/10.1111/all.70454

Source records